Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Oil & Gas, Technology and Consumer Goods sectors propelled shares higher while losses in the...
Amgen (AMGN) and AstraZeneca (AZN) announce TEZSPIRE (tezepelumab-ekko) is now available for shipment to wholesalers in the U.S.TEZSPIRE was approved by the FDA on Dec
BridgeBio Pharma (BBIO) announced a non-exclusive clinical collaboration with Amgen (AMGN) to jointly evaluate a potential combination therapy involving its SHP2 inhibitor,...
Passive-income seekers see the start of a new year as an opportunity to participate in the "Dogs of the Dow" strategy, an approach that involves buying 10 of the highest...
A number of health-care and biotech shares have recently been in the spotlight. In early October, Merck (NYSE:MRK)—covered in early November—gave a positive update on...
Blue-chip pharma stock Amgen is down over 8% so far in 2021.Its product offerings contain therapeutics for cardiovascular disease, oncology, haematology. inflammation and...
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Strong Buy | Buy |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 18.64 | 19.23 | 18.25 | -0.35 | -1.84% | 10.25M | Toronto | |||
| 66.08 | 67.77 | 65.27 | -0.06 | -0.09% | 7.90M | Toronto | |||
| 13.50 | 13.69 | 13.09 | +0.35 | +2.66% | 802.90K | Toronto | |||
| 6.40 | 6.90 | 6.40 | -0.500 | -7.25% | 2.43M | Toronto | |||
| 78.40 | 80.67 | 77.57 | -3.87 | -4.70% | 499.49K | Toronto | |||
| 20.90 | 21.35 | 20.83 | -1.46 | -6.53% | 25.31K | NEO | |||
| 103.29 | 104.04 | 103.04 | -0.86 | -0.83% | 5.82M | Toronto | |||
| 96.68 | 98.22 | 95.98 | -2.38 | -2.40% | 866.47K | Toronto | |||
| 3.27 | 3.39 | 3.26 | -0.27 | -7.63% | 954.01K | TSXV | |||
| 148.60 | 150.34 | 147.89 | -1.25 | -0.83% | 2.77M | Toronto | |||
| 42.10 | 45.03 | 42.00 | -3.69 | -8.06% | 1.25M | Toronto | |||
| 0.73 | 0.00 | 0.00 | -0.0700 | -8.75% | 2.26M | Toronto | |||
| 26.27 | 27.09 | 26.24 | -0.56 | -2.09% | 281.04K | Toronto | |||
| 25.60 | 25.60 | 25.55 | -0.06 | -0.23% | 1.20K | Toronto | |||
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | CSE |